16.07.2014 • NewsDede WillamsGlaxoSmithKline (GSK)GSK

Glaxo-Linked Foreign Investigators Said Indicted

Prosecutors in Shanghai have indicted Peter Humphrey, a 58-year-old UK citizen, and Yu Yingzeng, a 61-year-old US citizen, for illegally obtaining personal information on Chinese citizens, the official Chinese news agency Xinhua reports.

It is the first indictment Chinese prosecutors have announced of foreigners for conducting an illegal investigation, according to Xinhua.

The agency said local courts will hear the case of the two investigators at an unspecified date.

The couple, which registered their company, ChinaWhys, in 2004 in Shanghai, is accused of having illegally bought or obtained information through secret photography and infiltration.

According to Western news agencies, the company had previously been hired by Glaxo, which is under a bribery investigation in China.

China last year began an investigation into Glaxo's sales practices in the country, detaining some of its employees there.

On July 3, the drugmaker said ChinaWhys was hired last year to investigate a breach of privacy and security related to its China general manager.

The news agency Bloomberg said the office and mobile phone numbers for ChinaWhys' Shanghai headquarters appear to have been disconnected, and emails to the corporate account listed on the site were not answered. 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.